Skip to main content
Livermore
Livermore
ZHEN

Exchange Traded Concepts, LLC

SEC CIK
0001457320
Latest filing
Aug 11, 2026

SUPN holding history

Supernus Pharmaceuticals, Inc. in every 13F filed by Exchange Traded Concepts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SUPN overviewAll 13F holders of SUPNFull Q2 2026 holdings

Shares (Q2 2026)
40,971
Value
$1.91M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of SUPN by Exchange Traded Concepts, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202640,971$1.91M<0.1%+603+1.5%AddedHolders
Q1 202640,368$2.09M<0.1%+23,316+136.7%AddedHolders
Q4 202517,052$847.5K<0.1%−498−2.8%ReducedHolders
Q3 202517,550$838.7K<0.1%−7,815−30.8%ReducedHolders
Q2 202525,365$799.5K<0.1%+484+1.9%AddedHolders
Q1 202524,881$814.9K<0.1%+2,762+12.5%AddedHolders
Q4 202422,119$799.8K<0.1%+560+2.6%AddedHolders
Q3 202421,559$672.2K<0.1%+21,559NewHolders
Q1 20240$00.0%−42,189−100.0%Sold outHolders
Q4 202342,189$1.22M<0.1%+335+0.8%AddedHolders
Q3 202341,854$1.15M<0.1%+26,390+170.7%AddedHolders
Q2 202315,464$464.8K<0.1%−510−3.2%ReducedHolders
Q1 202315,974$578.7K<0.1%−3,964−19.9%ReducedHolders
Q4 202219,938$711.2K<0.1%+540+2.8%AddedHolders
Q3 202219,398$657.0K<0.1%−74−0.4%ReducedHolders
Q2 202219,472$563.0K<0.1%+444+2.3%AddedHolders
Q1 202219,028$615.0K<0.1%−27,607−59.2%ReducedHolders
Q4 202146,635$1.36M<0.1%+813+1.8%AddedHolders
Q3 202145,822$1.22M<0.1%+9,717+26.9%AddedHolders
Q2 202136,105$1.11M<0.1%+3,433+10.5%AddedHolders
Q1 202132,672$855.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.